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Abstract
Background: Drusen are extracellular lesions characteristic of aging and age-related maculopathy, a major retinal disease of
the elderly. We determined the relative proportions of lipids and proteins in drusen capped with retinal pigment epithelium
(RPE) and in RPE isolated from non-macular regions of 36 human retinas with grossly normal maculas obtained ,6 hr after
death.
Methodology/Principal Findings: Druse pellets were examined by light and electron microscopy. Component proteins
were extracted using novel methods for preserved tissues, separated, subjected to tryptic digestion and LC-MS(MS)
2
analysis using an ion trap mass spectrometer, and identified with reference to databases. Lipid classes were separated using
thin layer chromatography and quantified by densitometry. Major druse components were esterified cholesterol (EC),
phosphatidylcholine (PC), and protein (37.5613.7, 36.9612.9, and 43.0611.5 ng/druse, respectively). Lipid-containing
particles (median diameter, 77 nm) occupied 37–44% of druse volume. Major proteins include vitronectin, complement
component 9, apoE, and clusterin, previously seen in drusen, and ATP synthase subunit b, scavenger receptor B2, and
retinol dehydrogenase 5, previously seen in RPE. Drusen and RPE had similar protein profiles, with higher intensities and
greater variability in drusen. C8, part of the complement membrane attack complex, was localized in drusen by
immunofluorescence.
Conclusions/Significance: At least 40% of druse content is comprised by lipids dominated by EC and PC, 2 components
that are potentially accounted for by just one pathway, the secretion of lipoproteins by RPE. Manipulating genes encoding
apolipoprotein pathways would be a fruitful approach to producing drusen with high EC content in laboratory animals.
Therapies that directly mitigate drusen should prepare for the substantial volume of neutral lipids. The catalog of major
druse proteins is nearing completion.
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Introduction
Age-related maculopathy (ARM), a retinal disease affecting ,10
million older Americans, involves 4 distinct layers of the outer
retina: photoreceptors, retinal pigment epithelium (RPE, a layer of
nurse cells dedicated to photoreceptor health), Bruch’s membrane
(BrM, a 5-layer vessel wall underlying the RPE), and choriocap-
illaris (capillaries in the vascular bed with the body’s highest blood
flow). Drusen are focal deposits of extracellular debris located
between the basal lamina of the RPE and the inner collagenous
layer of BrM [1,2]. Found with advanced age in normal human
eyes [3,4], they are regarded as hallmarks of the underlying
degeneration of ARM. Numerous small hard drusen increase
significantly the incidence of large soft drusen and RPE
abnormalities that are, in turn, more likely to progress to advanced
disease [5]. Discrete and isolatable lesions amenable to multiple
assays, drusen are known to contain carbohydrates, zinc, and at
least 129 different proteins, including apolipoproteins and
excluding extracellular matrix [6,7,8,9,10,11,12]. Druse proteins
involved with inflammation and innate immunity (e.g., amyloid-b,
immunoglobulin light chains, factor X, C3, C5b-9 complex) have
received particular attention because sequence variants in several
complement proteins are associated with increased ARM risk
[13,14,15,16].
Virtually all drusen contain histochemically detectable lipid
[17,18,19,20,21], including cholesterol in 2 chemical forms,
unesterified (UC) and esterified to a long chain fatty acid (esterified
cholesterol, EC) [22]. EC and UC also accumulate in normal
human BrM throughout adulthood [19,20,23], of note because
aging is the largest risk factor for ARM. Elsewhere [24,25] we
summarized multiple lines of laboratory and clinical evidence
supporting the hypothesis that this accumulation can be attributed
to the retention of lipoprotein particles, 60–80 nm in diameter and
containing abundant EC, UC, phosphatidylcholine (PC), and
apolipoprotein B. The RPE is believed to secrete the lipoprotein
accumulating in BrM, without excluding the possibility that
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contribute. BrM lipoproteins are rich in the fatty acid linoleate and
poor in docosahexaenoate, and their density fraction contains
apolipoproteins B, A-I, and E. Ultrastructural studies indicate that
the concentration of lipoproteins is highest in the same tissue
compartment (inner BrM) as drusen and basal linear deposit, a
diffusely distributed drusenoid material specific to ARM [26].
ARM lesion formation has thus been conceptualized as sharing
mechanisms with atherosclerotic plaque formation, with a key
difference being that lipoproteins retained in BrM are of intra-
ocular origin unlike the plasma LDL retained in large arteries
[24,25].
Although drusen are often described as lipid-rich or lipid
containing, the exact proportion of protein and lipid in drusen is
unknown. The actual value of this proportion is important for
understanding how ARM-specific lesions form. Knowledge about
component abundance could direct attention to major contribut-
ing pathways in order to build better model drusen in laboratory
animals or to improve the molecular basis for mitigating or
eliminating drusen in patients. In this study we isolated drusen
with overlying caps of RPE, quantified total protein, identified
individual proteins by mass spectrometry, and quantified neutral
and polar lipid classes by thin layer chromatography. We analyzed
drusen from extra-macular (peripheral) retina from aged normal
eyes, as we have done previously [27,28,29], in order to maximize
sample size for our assays. Extra-macular retina represents 90% of
total retinal area and thus contains the numerical majority of
drusen, even in ARM eyes [30,31]. We elected to defer study of a
distinct druse sub-type in ARM macula associated with risk for
disease progression (‘‘soft’’) [5,32] for future studies with more
sensitive assays. Here we calculated mass of major components on
a per druse basis, unlike others who estimated druse component
abundance by the number of affected eyes (e.g., [33]) or the
number of affected drusen within an eye [10]. We find that the
lipids EC and PC may together account at least 40% of druse
volume.
Methods
Donor eyes and isolation of drusen
Institutional Review at the University of Alabama at Birming-
ham approved our use of human tissues. Eyes were obtained from
eye bank donors #6 hrs of death. RPE/choroid eyecups used for
total protein measurements were snap-frozen within scleral shells
using liquid nitrogen and stored at 280uC. Eyes used for all other
assays were preserved by immersion in either 4% paraformalde-
hyde or 1% paraformaldehyde/2.5% glutaraldehyde (Table 1),
both in 0.1 M phosphate buffer (PB), for 24 hrs following corneal
excision and stored in 1% paraformaldehyde at 4uC until used.
Eyes had grossly normal maculas and were chosen for use on the
basis of druse abundance in the peripheral retina. Most came from
older donors. Eyes chosen for use for protein identification by mass
spectrometry included several 7
th decade donors and therefore had
a younger mean age than the other groups [34].
All RPE-capped drusen were extra-macular and were collected
with a clearance of 3 mm from the outer circumference of the
6 mm-diameter macula. Drusen were mobilized from BrM with a
borosilicate pipette under stereomicroscopic guidance, herded into
groups, drawn into the pipette, placed into 1 ml vials containing
PB, and gently spun at 10,000 rpm to create a pellet. All drusen
within a peripheral retinal quadrant (1–2 quadrants per eye) were
harvested, without regard to size or type. Our target for the
number of drusen per eye was guided by previous experience with
enzymatic cholesterol assays [28]. Drusen were counted, as they
were isolated. Co-author LW collected drusen used for total
protein determinations, and co-author MEC isolated all others.
The volume occupied by drusen and RPE in pellets of RPE-
capped drusen was estimated from the area fraction of these
components in tissue cryosections [27,28,35]. We determined
cross-sectional areas of RPE and drusen from differential
interference contrast images, using a digitizing tablet and IP Lab
(Wacom Technologies; BioVision Technologies, Exton PA). To
allow comparison of a mixed sample (RPE-capped drusen) with
RPE alone, RPE in druse-free areas were also collected from the
same eyes.
Transmission electron microscopy
To facilitate handling, PB-washed drusen were covered with a
0.75%-agarose/5%-sucrose solution and refrigerated to form solid
agarose-encased pellets. Pellets were either extracted for 1 hr with
chloroform/methanol (2:1) [36] or left untreated prior to further
processing. Pellets were trimmed, post-fixed in 1% osmium in
0.1 M sodium cacodylate buffer, 1% tannic acid, and 1%
paraphenylenediamine (OTAP method [22,37]), dehydrated
through ethanol and propylene oxide, and embedded in epoxy
resin (PolyBed 812; Polysciences, Warrington PA). One-mm-thick
sections stained with 1% toluidine-O-blue were imaged with a
light microscope (Eclipse 80i; Nikon, Melville NY), 606 oil-
immersion objective, and digital camera (Retiga 4000R Fast; Q
Imaging, Burnaby, BC, Canada) [29]. Silver gold sections were
viewed on a JEOL1200 EXII electron microscope (JEOL USA,
Table 1. Summary of Eyes Used.
Purpose
#
Eyes
Age
(Mean ± SD)
Gender
(F/M)
# RPE-capped
Drusen
(Mean ± SD) Preservative Table code
TEM 2 79.562.1 2/0 2356108 Fix 2
NL (TLC) 14 77.1610.6 5/9 263678 Fix 2 Table 2, 1–7*
PL (TLC) 7 78.669.7 6/1 3106147 Fix 2 Table 2, 8–14
Protein (BCA) 7 88.066.5 4/2 386692 Frozen Table 4, 15–21
Protein (MS)** 6 66.2614.7 3/3 152670 Fix 1
Abbreviations: TEM: transmission electronic microscopy; BCA: bicinchoninic acid; MS: mass spectrometry; TLC: thin layer chromatography; NL: neutral lipid; PL: polar
lipid; Fix 1: 4% paraformaldehyde in 0.1M phosphate buffer; Fix 2: 2.5% glutaraldehyde and 1% paraformaldehyde in 0.1 M phosphate buffer.
* 14 eyes were assayed in 2 groups, with similar results; one group is reported.
** 6 for RPE-capped drusen, 5 for RPE.
doi:10.1371/journal.pone.0010329.t001
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(Advanced Microscopy Techniques, Danvers MA).
Two sets of measurements were made using digital electron
micrographs (20,0006 original magnification, 255063300 pixel
tiff format files). First, the proportion of electron-dense lipid-
containing material in individual drusen was calculated using the
segmentation functions in IP Lab. From the Analyze\Segmenta-
tion menu, the lower bound of the intensity threshold was set at 1
to include small electron-dense particles, and the upper bound was
set empirically to include all large particles. The Modify
Segment\Erode function was used to separate confluent particles,
and then the total area of particles was determined and expressed
as percentage of total druse area. Second, the diameter of ,900
individual electron-dense particles was determined by tracing with
the digitizing tablet and calculating equivalent diameter according
to the formula for a circle.
Thin layer chromatography (TLC), one-dimensional, and
densitometry for lipids
Lipids were extracted from RPE-capped drusen and RPE using
chloroform-methanol (2:1 v/v) [36] as described [38,39]. Aliquots
of organic phase were evaporated under nitrogen, re-solubilized in
chloroform, and applied to TLC plates (LHPKD silica gel 60A,
Whatman). To separate neutral lipids EC, triglyceride (TG), UC,
and fatty acids (FA), plates were developed in petroleum ether:
diethyl ether: acetic acid (84:15:1). To separate polar lipids PC and
sphingomyelin (SPM), plates were developed in chloroform:
methanol: ammonium hydroxide (65:25:4). Plates were sprayed
with 3% copper acetate in 8% phosphoric acid solution and
heated to reveal bands. Standards were chloroform-solubilized
1,2-dioleoyl-sn-glycero-3-phosphocholine, oleate, triolein, choles-
teryl oleate, SPM esterified to mostly palmitate (16:0), and UC
(SPM from Avanti Polar Lipids, Alabaster AL; others from Sigma).
Each plate containing samples contained standards run at five
dilutions (1, 1:2, 1:4, 1:8, 1:16) in order to generate a standard line.
Plates were scanned, bands of samples and standards defined, and
densities measured using an ImageQuant 400 Scan CCD imaging
system and ImageQuant 400 Capture software (version 1.0.0, GE
Healthcare, Piscataway NJ). Densities were converted to concen-
trations on a per plate basis using the standard line for that plate
and Excel (Microsoft). In the tables, we report ‘‘total measured
lipids,’’ because certain lipid classes, e.g., phosphatidylethanol-
amine, were not assayed.
Total protein in RPE-capped drusen
Proteins were extracted from fresh-frozen RPE-capped drusen
by T-PERH Tissue Protein Extraction Reagent (catalog # 78510,
Pierce Inc, Rockford IL). Protein concentration was measured
using bicinchoninic acid protein assay kits (catalog #23227, Pierce
Inc) according to the manufacturer’s instructions. Briefly, 100 mlo f
protein extraction reagent were added into RPE-capped drusen
samples and homogenized. Samples were centrifuged at 10,0006g
for 5 minutes to pellet tissue debris, and supernatant was collected.
Duplicate samples at 1:5 and 1:10 dilutions were measured using a
microplate reader (Model V Max; Molecular Devices, now MDS
Analytical Technologies). We report the average of these 2
replicates, which were highly similar.
Identification of proteins via mass spectrometry and
bioinformatics
Drusen Protein Extraction. Following harvesting, druse
samples were kept in PB saline (PBS) at 4uC for ,3 wk. All steps
occurred at room temperature unless noted. Each sample was
washed three times in PBS and centrifuged at 14,0006g for 2 min,
and the PBS discarded. Proteins were extracted using the
Qproteome FFPE Tissue kit (Qiagen) following the manu-
facturer’s instructions, with modifications necessitated by the use
of paraformaldehyde-fixed tissues. Each sample was re-suspended
in 25 mL of Qiagen EXB, incubated at 100uC for 20 min and then
at 80uC, 750 rpm for 2 hr. The samples were centrifuged at 4uC,
14,0006g for 15 min. Supernatant containing extracted proteins
was transferred to a fresh tube. Protein content was quantified
using EZQuant (Invitrogen). Two hundred ng of protein per
sample was separated on a 4–12% Novex Tris-Glycine gel
(Invitrogen) at a constant 125V for 15 min. The gel was stained
overnight with Colloidal Blue (Invitrogen) and de-stained in
distilled water for 3 hr. One intense band per lane was excised and
digested overnight with trypsin (Promega) following the
manufacturer’s instructions. Digests were extracted using 15 mL
of 60% acetonitrile/0.1% trifluoroacetic acid. Extracts were dried
with a speed vacuum and reconstituted in 10 mLo f5 %
acetonitrile/0.1% formic acid. The entire extract of each sample
was used for mass spectrometry, as described below.
Protein Identification. Extracted and de-crosslinked
proteins were subjected to standard analytic techniques. LC-
MS(MS)
2 analysis of the tryptic digest peptides was performed
using a ThermoFinnigan LTQ-XL ion trap mass spectrometer
equipped with a Thermo MicroAS autosampler and Thermo
Surveyor HPLC pump, Nanospray source, and Xcalibur 1.4
instrument control (ThermoFinnigan, San Jose, CA). Peptide
fractions were diluted by a factor of 10 in 0.1% formic acid prior
to separation on a packed capillary tip, 100 m611 cm, with C18
resin (Jupiter C18, 5 m, 300 Angstroms, Phenomenex, Torrance,
CA). The flow rate during the solid phase extraction phase of the
gradient was 3 mL/min and 500 nL/min during the separation
phase. Mobile phase A was 0.1% formic acid, mobile phase B was
acetonitrile with 0.1% formic acid. A 95 min gradient was
performed with a 15 min washing period (100% A for the first
10 min followed by a gradient to 98% A at 15 min) to allow for
solid phase extraction and removal of any residual salts. After the
initial washing period, a 60 min gradient was performed where the
first 35 min was a slow, linear gradient from 98% A to 75% A,
followed by a faster gradient to 10% A at 65 min and an isocratic
phase at 10% A to 75 min. MS/MS scans were acquired using
an isolation width of 2 amu, an activation time of 30 ms,
and activation Q of 0.250 and 30% normalized collision energy
using 1 micro-scan and maximum injection time of 100 ms
for each scan. The mass spectrometer was tuned prior to
analysis using the synthetic peptide TpepK (AVAGKAGAR).
Typical tune parameters were spray voltage=1.8 kV, capillary
temperature=150uC, capillary voltage=50 V, and tube
lens=100 V. The MS/MS spectra of the peptides were
acquired using data-dependent scanning in which one full MS
spectrum using a mass range of 400–2000 amu was followed by
three MS/MS spectra.
Database searches, statistical analysis, and systems
biology. Proteins were searched in species-specific subsets of
the UniRef database. Tandem mass spectrometry data were
converted to mzXML format using instrument-specific conversion
software (Institute for Systems Biology, Seattle WA; Fred
Hutchinson Cancer Center) and run separately through
SEQUEST (ThermoFisher), X!TANDEM (Global Proteome
Machine Organization), and MASCOT (Matrix Science Inc.,
Boston MA) software. Top-matching algorithms from all 3
packages were utilized in order to increase confidence in protein
identifications and decrease the propensity for false negatives.
Combined data were analyzed using Protein Prophet (Institute for
Lipids and Proteins in Drusen
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specific peptide fragmentation pattern.
Further analysis used Refiner MS and Analyst software
(Expressionist Genedata) to align mass and time tags of ion plots
generated from the post LCMS run, followed by common
statistical analysis using Analyst and manual input of threshold
values. Selection of important proteins utilized common non-
parametric statistical tools (Kruskal-Wallis, Fisher’s exact test, and
permutation t-test). Proteins were considered important based on
significance values obtained with these tests, fold change, and
ability to identify the same peptide with high confidence in 50% or
greater in either RPE-capped drusen or RPE. Spectral count
intensities from mass spectrometry for each of 20 proteins from
RPE-capped drusen (n=6 eyes) and RPE (5/6 eyes) were
exported to an Excel spreadsheet. Ion intensity data were also
imported into the program Mayday (version 2.9, Tu ¨bingen,
Germany), log transformed (base 10), and visualized using the
enhanced heat map feature of this program. A list of UniRef
referenced IDs for the most important proteins were uploaded to
Ingenuity Pathways Analysis (www.ingenuity.com), which maps all
proteins to previously referenced cellular components indexed in
the Gene Ontology databases (www.geneontology.org).
Indirect immunofluorescence
Cryosections of isolated drusen were used for immunofluores-
cence performed as described [27]. Goat antiserum to human C8
(Quidel, cat# A309) was used at a concentration of 1:200.
Identical concentrations of goat IgG were used on negative control
sections. Slides were incubated with biotinylated anti-goat IgG
1:500 for 2 hr at room temperature, washed, and incubated with
rhodamine Red-X-conjugated streptavidin (1:500; Jackson Im-
munoResearch, West Grove PA). After washing, coverslips were
mounted with Aqua Poly/Mount (Polysciences, Inc., cat#
526956. Sections were examined with 106 planapo and 406
plan fluor objectives and filter cubes for rhodamine and
autofluorescence (in nanometers, excitation-dichroic-barrier,
540/25–565-630/60 and 480/30 –505-535/40, respectively).
Determining lipid and protein content of RPE-capped
drusen
To compare protein and lipid components of RPE-capped
drusen, results of bicinchoninic acid and TLC assays were
converted to units of ng per druse. Protein concentrations were
originally expressed in terms of mg albumin equivalents per ml of
extract from a known number of drusen. The concentration of
different lipid classes detected by TLC, originally expressed in
nmole/mL [40] was converted to ng/ml using the molecular weight
of standard lipids for each class (i.e., cholesteryl oleate for EC), and
then divided by the number of drusen in the sample. To compare
compositional data from drusen, which are countable, and RPE,
which is not, measures of content were normalized by dry weight.
Results
A total of 36 eyes from 36 adult donors with grossly normal
maculas were used for different assays (Table 1). The number of
RPE-capped drusen harvested per eye ranged from 152 to 386.
Figure 1. Lipid localization in isolated RPE-capped drusen. A.
Light micrograph of RPE-capped drusen, isolated from extra-macular
retina, pelleted, post-fixed by the OTAP method, and sectioned (1 mm).
Two drusen in the panel are both considered hard. Bar, 50 mm. B, C.
Transmission electron micrographs of RPE-capped drusen that are either
untreated (B-1, B-2) or extracted with chloroform-methanol to remove
lipids (C-1, C-2). RPE is at the top of B-1 and C-1. B-1, B-2. Drusen have
abundant electron-dense (dark) lipid droplets. L, lipofuscin granule; d,
druse interior; arrowhead, basal infolding; asterisk, basal laminar deposit.
Barin B-1, 1 mm. Bar in B-2, 200 nm.C-1, C-2. Lipid droplets areremoved
by chloroform-methanol extraction, leaving electron-lucent profiles (C-2).
doi:10.1371/journal.pone.0010329.g001
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Figure 1. Drusen are randomly oriented in these sections. Most
drusen are of the hard type, i.e., they are dome shaped with solid
interiors and homogeneous contents, and a median diameter of
47 mm [29]. The RPE layer is intact overlying the druse, and
because outer segments are occasionally attached, we infer that the
entire apical to basal extent of RPE is present. By measuring the
cross-sectional areas of drusen and RPE in sections of pelleted
RPE-capped drusen (see Methods), we determined that the
component volume fraction was 62.4%612.8% for drusen and
37.6%612.81 for RPE. Thus, assays of RPE-capped drusen
described below are dominated by values for druse contents. In
electron micrographs of OTAP prepared drusen, lipid-containing
components take the form of spherical or ovoid particles that are
electron dense and dispersed (Figure 1B-1, B-2). That these
components are lipid containing is demonstrated by treatment
with the lipid solvent chloroform – methanol, which converted
areas of electron-density to electron-lucent spaces (Figure 1C-1,
C-2). The lipid-containing components were quantified individ-
ually and in the aggregate in Figure 2. Particle diameters varied
across a single-mode, positively skewed distribution with a median
of 77.4 nm, with some profiles .200 nm. The area fraction of the
electron-dense lipid containing material within individual drusen
was 0.44 and 0.37 in two eyes.
To determine the lipid components of RPE-capped drusen,
lesions were extracted with chloroform – methanol, and these
extracts were separated using solvent systems for neutral lipids and
polar lipids. Table 2 shows that mean total lipid measured per
RPE-capped druse was 112.42 ng/druse. While cognizant that
combining data from these two assays has limitations, we can draw
some conclusions. The polar lipids (PC and SPM, mean 61.13 ng/
druse) were more abundant than the neutral lipids (EC, TG, FA,
and UC, mean 51.30 ng/druse) in 4/7 eyes and less abundant in
3/7 eyes, indicating no strong trend towards dominance by one
group. The two most abundant lipids measurable by these assays
were EC and PC (37.47 and 36.89 ng/druse, respectively). Within
the neutral lipids, EC was the dominant class, with values 4-fold or
higher than the next highest class (FA). Within the polar lipids, PC
was more abundant than SPM by 50% (paired t-test, p=0.008).
To compare lipid profiles of RPE-capped drusen and RPE from
the same eyes, lipid classes detected by TLC were expressed as
percentages of dry weight, pooled across all eyes, in Table 3.
Figure 2. Lipid-containing particles in drusen. Electron-dense profiles were measured by digital planimetry in electron micrographs of drusen
like Figure 1B-1, B-2, and equivalent diameters were determined. Descriptive statistics for this population of ,900 particles are shown. Area fraction,
the proportion of druse cross-sectional area occupied by electron-dense lipid, is reported for 2 eyes. See Methods for measurement details.
doi:10.1371/journal.pone.0010329.g002
Table 2. Measured Lipid Components in RPE-capped Drusen (ng/druse).
Case # EC TG FA UC
Total Measured
Neutral Lipids Case # SPM PC
Total Measured
Polar Lipids
Total
Measured Lipids
1 30.76 0.00 8.13 3.93 42.82 8 19.06 47.05 66.11 108.93
2 65.59 0.00 14.56 7.17 87.32 9 25.46 31.14 56.60 143.92
3 26.88 2.59 5.85 2.80 38.12 10 19.89 28.89 48.78 86.88
4 26.35 4.45 7.71 3.89 42.40 11 30.43 54.67 85.10 127.50
5 41.68 0.00 8.41 3.68 53.77 12 23.31 27.54 50.85 104.61
6 31.71 0.00 7.44 3.65 42.80 13 18.31 20.72 39.03 81.83
7 39.29 0.00 8.51 4.05 51.85 14 33.23 48.19 81.42 133.27
Mean 37.47 1.01 8.66 4.17 51.30 Mean 24.24 36.89 61.13 112.42
SD 13.70 1.80 2.75 1.39 16.84 SD 5.81 12.86 17.22 23.51
doi:10.1371/journal.pone.0010329.t002
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differed distinctly, as 4.82% of the dry weight of RPE-capped
drusen was EC, compared to 1.18% for RPE. For both neutral
and polar lipids, RPE-capped drusen were enriched 4–6 fold
relative to RPE. To compare lipid profiles of RPE-capped drusen,
RPE, and previously published values for isolated BrM particles
assayed by preparative liquid chromatography/gas chromatogra-
phy [39], the mole percent of each class relative to the total of the
6 lipid classes measured is shown in Figure 3. All three samples
were highly enriched in EC (30–35%). RPE and RPE-capped
drusen, measured in this study, resembled each other but differed
from BrM particles by being more enriched in FA and PC (by
factors of ,2), and much less enriched in UC.
To compare the overall protein content of RPE-capped drusen
to their lipid content, total protein was determined using frozen
(unfixed) drusen and a standard bicinchoninic acid assay, using
albumin as a standard (Table 4). Each RPE-capped druse
contained 42.96611.48 ng protein. A comprehensive examination
of protein composition was achieved by mass spectrometric
analysis of RPE-capped drusen and RPE. Table 5 lists 20
proteins meeting quality criteria stated in the Methods. This list
includes individual proteins that are well established as druse
constituents (apoE, clusterin or apoJ, complement factor H,
TIMP-3, and vitronectin). It also includes proteins associated with
cellular function (ATP synthase b subunit, scavenger receptor B2,
and retinol dehydrogenase 5) and previously described in RPE
[41,42,43,44]. Members of the final complement pathway
comprising the membrane attack complex (components 5, 6, 8,
9) exhibited strong ion intensities, notably the 3 subunits of C8 (a,
b, c). C8 immunoreactivity was present in all drusen examined
using immunofluorescence and an antibody recognizing the 3
subunits (Figure 4). Definitive identification of C8 within RPE
was precluded by the intense autofluorescence and pigmentation
of these cells.
To facilitate comparison of the relative abundance of 20 index
proteins in RPE-capped drusen and RPE, mean ion intensities for
all samples were plotted in a heat map, and sorted by druse signal
strength (Figure 5). The proteins with the 6 highest ion intensities,
which should not be confused with actual abundance, were
vitronectin, complement component 9, apoE, clusterin (apoJ),
TIMP-3, and serum amyloid A1. Overall, the protein profile was
similar in RPE-capped drusen and RPE, with higher intensities
and greater variability in the drusen, not surprising given the
greater volume of the sample taken up by drusen. However,
differences in intensities between RPE-capped drusen and RPE
were on the order of a log unit, much greater than the 2-fold
Figure 3. Lipid Composition. Mole% of major lipid classes in RPE-capped drusen, RPE, as determined by thin-layer chromatography and
densitometry compared to that in BrM lipoprotein particles [39]. Abbreviations for 6 lipid classes are given in the notes to Table 2. As described in the
Methods, EC, TG, FA, and UC were separated by a petroleum ether: diethyl ether: acetic acid solvent system, and SPM and PC were separated by
chloroform: methanol: ammonium hydroxide.
doi:10.1371/journal.pone.0010329.g003
Table 3. Lipid Fractions of RPE-capped Drusen and RPE (% of dry weight).
RPE-capped
Drusen RPE
Ratio
(RPE-capped drusen/RPE)
Neutral Lipid EC 4.82% 1.18% 4.08
TG 0.19% 0.04% 4.75
FA 1.59% 0.29% 5.48
UC 0.52% 0.10% 5.20
Total Measured NL 7.11% 1.60% 4.44
Polar Lipid SPM 3.72% 0.57% 6.53
PC 5.38% 0.92% 5.85
Total Measured PL 9.10% 1.49% 6.11
doi:10.1371/journal.pone.0010329.t003
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appear much more highly concentrated within drusen than in
RPE.
Per druse, the combined weight of the lipids measured
(112.42 ng, Table 2) was almost 3-fold larger than the weight of
proteins (42.96, Table 3). Approximately equal quantities of EC,
PC, and protein were detected. The average weight of an
individual RPE-capped druse was 892 ng, so the total of
155.38 ng lipids and proteins accounts for 17.4% of total druse
weight. The unaccounted-for weight includes both components
not detectable by our methods and incomplete extraction of
proteins and lipids.
Discussion
Multiple levels of significance have been ascribed to the
molecules trapped or sequestered in drusen. These include toxicity
to the overlying RPE, stigmata of formative processes such as
extrusion or secretion of cellular materials, extracellular enzymatic
processing, cellular invasion or activity, and markers of a diffusely
distributed disease process affecting RPE and BrM. We sought to
identify abundant druse components under the assumption that
such information would both permit research to focus on major
contributory pathways and allow the informed construction of
improved in vivo and in vitro model druse systems. Study strengths
are the repeatability of results from large sample of eyes, the use of
morphometric and analytic techniques, development of new
protein extraction methods for archival preserved material, and
the availability of previous studies against which our protein list
could be validated (see below). Without more information about
other druse components (e.g., carbohydrates or zinc [6] [12]), we
cannot yet express abundance as proportions of total weight.
Further, other assays will be required to identify and quantify the
modified lipids and proteins [9,45,46] that are widely believed to
accompany ARM progression.
We find that lipids, dominated by EC and PC, account together
for 37–44% of druse content, on the basis of extraction with
appropriate solvents and ultrastructural stereology. A much higher
Table 4. Protein Concentration and Mass in Drusen.
Case # Drusen #
Total protein
(ng)
Protein
(ng/druse)
Protein
(ng/mg druse)
15 482 15447 32.05 4.35
16 412 24482 59.42 1.95
17 262 10974 41.89 1.53
18 365 13725 37.60 1.98
19 276 15846 57.41 2.70
20 500 21030 42.06 2.20
21 410 12415 30.28 0.86
Mean 387 16274 42.96 2.22
SD 93 4836 11.48 1.10
doi:10.1371/journal.pone.0010329.t004
Table 5. Proteins Detected in RPE-capped Drusen and RPE.
Protein Name
Gene
Symbol ID Location*
%
Coverage
# Unique
Peptides
Albumin, serum ALB P02768 ES 6.7 6
Amyloid P component, serum APCS P02743 ES 31.8 8
Apolipoprotein E APOE P02649 ES 36.0 14
ATP synthase, H
+ transporting, mitochondrial F1 complex, b polypeptide ATP5B P06576 Cyto 26.1 9
Clusterin CLU P10909 ES 9.0 1
Complement component 5 C5 P01031 ES 16.6 28
Complement component 6 C6 P13671 ES 15.4 11
Complement component 8, a polypeptide C8A P07357 ES 14.2 4
Complement component 8, b polypeptide C8B P07358 ES 11.8 3
Complement component 8, c polypeptide C8G P07360 ES 47.8 6
Complement component 9 C9 P02748 ES 29.0 21
Complement factor H CFH Q03591 ES 17.7 3
Enolase 2 (c, neuronal) ENO2 P09104 Cyto 7.8 2
Forkhead-associated (FHA) phosphopeptide binding domain 1 FHAD1 B1AJZ9 Unk 0.0[
1]0
Major histocompatibility complex, class II, DR a HLA-DRA P01903 PM 27.6 5
Retinol dehydrogenase 5 (11-cis/9-cis) RDH5 Q92781 Cyto 22.6 8
Scavenger receptor class B, member 2 SCARB2 Q14108 PM 2.5 2
Serum amyloid A1 SAA1 P02735 ES 0.0[
2]0
TIMP metallopeptidase inhibitor 3 TIMP3 P35625 ES 60.2 15
Vitronectin VTN P04004 ES 27.4 15
Notes: Locations assigned by Gene Ontology.
Abbreviations: ES: extracellular space; Cyto: cytoplasm; PM, plasma membrane; Unk, unknown.
* Location refers to location of most widely recognized function for each protein; even proteins in extracellular space begin within the endoplasmic reticulum of a
source cell.
doi:10.1371/journal.pone.0010329.t005
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through thin-layer chromatography and densitometry should be
considered an upper limit and less definitive. It is possible that this
larger proportion, obtained by normalizing results of protein and
lipid assays by druse number, reflected an underestimate of total
protein, operator-dependent differences in sample collection (see
Methods), or limitations inherent in comparing assays of different
precision. Further, our observation of high lipid enrichment of
drusen relative to RPE is tempered by RPE PC content was low,
considering PC comprises 20–40% of typical cellular phospholip-
ids [47] Despite these uncertainties, we can safely conclude that
EC and PC account together for at least 40% of druse content.
Further, these 2 components are potentially accounted for by just
one pathway, the retention of lipoproteins secreted by RPE [25]
(see below). We also confirmed major druse proteins seen by
others, suggesting the catalog of these components is nearing
completion.
Catalog of druse proteins
Protein identification in this study was challenged by the use of
archival paraformaldehyde- preserved tissue and a sample (RPE–
capped drusen) that was both small and of mixed origin. We
developed novel methods that entailed de-crosslinking proteins. A
key step in this procedure was a Tris-Glycine 1D PAGE gel to
remove contaminants prior to mass spectrometry analysis. We
sought to obviate concerns about mixed samples by also analyzing
RPE isolated from the same eyes. We obtained robust signals for
20 proteins, 18 of which were common to RPE-capped drusen and
RPE. Of direct interest to retinal lipid homeostasis was SCARB2.
The class B scavenger receptors, SR-BI and SR-BII, are nearly
identical, differing only at the C-terminus due to alternative gene
splicing [48] [49]. Scavenger receptors, expressed by RPE [50,51],
bind plasma HDL, a postulated delivery route for carotenoid
micronutrients essential for retinal and RPE health [52,53].
Sequence variants in SCARB1 have been associated with
increased risk for ARM [54].
In Table 6, we compare our 20 proteins to previous literature
using proteomics or immunohistochemistry in native RPE and
RPE-derived cell lines plus a recent description of the human RPE
transcriptome [9,13,41,43,55,56,57,58,59,60,61,62]. This com-
parison indicates that we detected many previously described
druse proteins, and 18 of our 20 proteins match to the RPE
transcriptome [62]. This comparison thus validates the new
extraction and de-cross-linking techniques and solidifies the list of
known major players by identifying the proteins that are
abundant, survive fixation and cross-linking, and are readily
ionizable. Collectively our data also support the idea that many
druse proteins, although best characterized in other organ systems,
are potentially produced locally within the eye. However, it is
possible that RPE from donors without drusen, not examined
herein, would not have as strong a signal for druse proteins. We
emphasize that comprehensive proteomics in this study did not
reveal some proteins revealed repeatedly by other methods, such
as apolipoproteins B and A-I, amyloid (fibrillar and non-fibrillar),
and complement component 3 [10,11,63,64], thus underscoring
the importance of replication via multiple approaches.
Of the complement components in drusen, three subunits of C8
were detected by mass spectrometry and then confirmed using
immunofluorescence. C8 belongs to the C5b-9 membrane attack
complex, previously detected in drusen and BrM using antibodies
Figure 4. Complement factor 8 (C8) confirmed in drusen. Each column shows the same isolated RPE-capped drusen viewed with differential
interference contrast microscopy (A,D), a rhodamine filter cube for immunofluorescence (B,E), and immunofluorescence merged with
autofluorescence visualized with a fluorescein filter cube, resulting in a bronze -colored RPE (C,F). A, B, C. C8 immunoreactivity D, E, F. Control
experiment using goat IgG.
doi:10.1371/journal.pone.0010329.g004
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complement components comprised of subunits (a, b, c), all
products of separate genes. A secreted disulfide-linked C8 a-c
dimer (which interacts with C5b-7) associates non-covalently with
C8b (which then interacts with C9 monomers) [67]. Our data
strengthen evidence for a role of this terminal complement
component in druse pathogenesis.
Mechanisms of lipid deposition in drusen and Bruch’s
Here we found that EC and PC, two of the major lipid classes
recently quantified for BrM lipoproteins [39], together accounted
for at least 40% of druse volume. We could not obtain more details
about the fatty acid distribution in these classes, as our samples
were too small for comprehensive lipid profiling via liquid
chromatography – gas chromatography using our previously
published methods [39]. Thus, we could not directly compare fatty
acids esterified to cholesterol in drusen to those in lipoproteins
from plasma and BrM. Both of these lipoprotein sources have
abundant cholesteryl linoleate (associated with dietary origin) and
little cholesteryl docosahexanoate (associated with retinal origin)
[39].
As revealed previously by filipin histochemistry, EC and UC are
diffusely distributed through all drusen, with subregions of higher
accumulation such as EC-rich shells, UC-rich cores, and lakes of
pooled EC [19,21,68]. We previously showed electron dense
particles in drusen post-fixed to preserve neutral lipid ([27], Fig. 6).
Here we confirmed the lipophilic nature of these particles via
extraction studies and showed that they are dispersed evenly
throughout an apparently proteinaceous ground material. Both
the size range and spatial distribution of the electron dense
material are consistent with previous histochemical and ultra-
structural findings and with the interpretation that these are
lipoprotein particles like those in BrM, in either native or modified
form. These data suggest a model of druse formation and
Figure 5. Proteins in RPE-capped Drusen and RPE. Spectral count ion intensities from mass spectrometry for each of 20 proteins meeting
quality criteria (see Methods) from RPE-capped drusen (n=6 eyes) and RPE (5 of the same 6 eyes). The ion intensity data was log transformed (base
10), visualized using the enhanced heat map feature in Mayday version 2.9 and sorted by druse signal strength. Similar proteins were detectable in
drusen and RPE, with a log unit higher intensities in drusen.
doi:10.1371/journal.pone.0010329.g005
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within a relatively more hydrophilic matrix, followed by particle
fusion and lipid pooling.
While retention of RPE-secreted lipoproteins may account for
much druse lipid, this process cannot account for all of it, because
the composition we observed differs from lipoprotein composition
by having both lower UC and higher fatty acids. Other sources
must therefore contribute, and higher fatty acids may indicate
post-mortem degradation of complex lipids (see [69]). Other
explanations for this finding include a greater sensitivity of our
chromatographic detection system for free fatty acids, or
modification locally by enzymes such as lipoprotein lipase [70].
Proportionately less UC in drusen relative to lipoproteins was
unexpected, in that evidence is accruing that proteins associated
with RPE plasma and organelle membranes are shed into BrM
and drusen [59,71,72,73,74,75,76], as long suspected [77].
Perhaps the UC content of those membranes is reduced before
being shed.
Our focus on extra-macular drusen, dictated by convenience in
isolating large quantities, does not preclude cautious inference
from our conclusions to macular drusen, the universally agreed-
upon predictors of ARM progression [5]. Elsewhere we demon-
strated that macular drusen from ARM eyes contain abundant
EC, UC, and apolipoproteins B and E [10,21]. Soft drusen,
dominant in the macula, contains a very high proportion of
membranous coils. Originally termed membranous debris [78],
this material has solid, neutral lipid cores when post-fixed for
improved lipid preservation [22], prompting our suggestion of
‘‘lipoprotein-derived debris’’ as a better name. This term more
accurately invokes a mechanism that could account for the
presence of both UC and EC in these lesions [21,22,25], without
prohibiting a role for other mechanisms for UC deposition (see
above). Indirect evidence from the physical fragility of macular soft
drusen suggests that these lesions may be proportionally more
lipid-rich than the extra-macular drusen studied here [10,29].
Thus, our estimate of extra-macular druse lipid content can be
considered lower bounds for the content of the more fateful lesions
in the ARM macula.
Within drusen, the association of lipid components plausibly
derived from lipoproteins with strong signals from complement-
related molecules is especially intriguing, given the multiple
polymorphisms in complement factors that influence AMD
susceptibility [14,15,16]. Our data suggest that lipoproteins in
native or modified form, already described by others in human
BrM [45,46,79,80,81], could be a potent stimulus for complement-
mediated activation, as it is in atherosclerotic artery walls [82].
Implications for model building and for treatment
Information from human eyes presented herein will help
constrain and inform improved model systems for ARM. ARM-
relevant choroidal neovascularization and cell loss have been
productively studied in mouse models but bona fide drusen have
been a more elusive target [83,84]. Whether this situation is
because mice lack maculas or because the relevant pathways for
druse formation have not been identified remains uncertain.
However, as EC and PC plausibly come to drusen as part of apoB
lipoproteins secreted by RPE, just this one mechanism could
account for 40% or more of druse volume. Manipulating genes
encoding apolipoproteins pathways, including apoB, should
therefore be a fruitful approach to faithfully replicating drusen
with high EC content like those found in humans. Indeed, mouse
models of age-related BrM lipid deposition based on such
manipulations have been reported [85,86,87,88,89]. Conversely,
our data also suggest that the contribution of any one protein to
druse volume is likely small, and that in order to achieve abundant
deposition, several druse proteins may have to be over-expressed,
perhaps in combinations.
Our data also imply that direct mitigation of drusen via
interference with biosynthesis and/or translocation of major druse
components EC, UC, and PC should be contemplated as
therapeutic routes in ARM. RPE re-populates BrM poorly
following surgical extirpation of choroidal neovascular membranes
in older patients [90], leading to intensive efforts to optimize the
substrate for RPE survival by rejuvenating aged BrM [90,91,92].
In order for BrM to serve as a surgical bed for autologous grafts or
stem cells to replace damaged RPE and photoreceptors [93], lipid-
sequestering or -solubilizing approaches, using detergents, neutral
pH cholesterol esterases, reconstituted HDL, apolipoprotein
mimetics, and bioremediation should be included in BrM
refurbishing [90,94,95,96,97].
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Table 6. Comparison with Other Studies.
Gene
Symbol
Drusen
Prot
Drusen
IHC RPE Prot LF Prot Bleb Prot mRNA
A L B X XX XX
APCS X X
APOE X X X
ATP5B X X X X X
CLU X X X X
C5 X X
C6 X X
C8A X X
C8B X
C8G X X
C9 X X X
CFH X X
ENO2 X X X
FHAD1
HLA-DRA X X
RDH5 X X X
SCARB2 X X
SAA1 X X
TIMP3 X X X X
VTN X X X X X
See Table 4 and Figure 5 for protein names.
Drusen Prot: proteomics [9]; Drusen IHC: immunohistochemistry [13,60,61]; RPE
prot: native; human RPE proteomics [55]; LF prot: RPE lipofuscin proteomics
[57]; Bleb prot: ARPE-19 cell lines exposed to hydroquinone [59]; mRNA: human
RPE [62]; Individual proteins, by proteomics – ENO2, normal and diabetic
human RPE [58]; ATP5B, human RPE mitochondria [41,42] and human RPE
melanolipofuscin [56] – and by immunohistochemistry – SCARB2 in monkey
RPE [43].
doi:10.1371/journal.pone.0010329.t006
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